The impacts of Chinese drug volume-based procurement policy on the use of policy-related antibiotic drugs in Shenzhen, 2018–2019: an interrupted time-series analysis

被引：0
|
作者：
Ying Yang
Lei Chen
Xinfeng Ke
Zongfu Mao
Bo Zheng
机构：
[1] Wuhan University,School of Health Sciences
[2] Wuhan University,Global Health Institute
[3] Peking University First Hospital,Institute of Clinical Pharmacology
[4] Peking University First Hospital,Department of Pharmacy
来源：
BMC Health Services Research | / 21卷
关键词：
National Centralized Drug Procurement (NCDP) policy; "4 + 7"; volume-based procurement; antibiotic use; China;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 43 条
  • [1] The impacts of Chinese drug volume-based procurement policy on the use of policy-related antibiotic drugs in Shenzhen, 2018-2019: an interrupted time-series analysis
    Yang, Ying
    Chen, Lei
    Ke, Xinfeng
    Mao, Zongfu
    Zheng, Bo
    BMC HEALTH SERVICES RESEARCH, 2021, 21 (01)
  • [2] The impact of the national volume-based procurement policy on the use of policy-related drugs in Nanjing: an interrupted time-series analysis
    Xiao Wang
    Xuan He
    Pei Zhang
    Mengdie Zhang
    Rui Ma
    Rouli Dai
    Xin Li
    International Journal for Equity in Health, 22
  • [3] The impact of the national volume-based procurement policy on the use of policy-related drugs in Nanjing: an interrupted time-series analysis
    Wang, Xiao
    He, Xuan
    Zhang, Pei
    Zhang, Mengdie
    Ma, Rui
    Dai, Rouli
    Li, Xin
    INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH, 2023, 22 (01)
  • [4] Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis
    Wang, Ni
    Yang, Ying
    Xu, Luxinyi
    Mao, Zongfu
    Cui, Dan
    BMC PUBLIC HEALTH, 2021, 21 (01)
  • [5] Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis
    Ni Wang
    Ying Yang
    Luxinyi Xu
    Zongfu Mao
    Dan Cui
    BMC Public Health, 21
  • [6] Impacts of national volume-based drug procurement policy on the utilization and costs of antihypertensive drugs in a Chinese medicine hospital: an interrupted time series analysis of 5138 patients
    Shang, Lili
    Cheng, Yan
    Zhou, Jifang
    Bao, Yuqing
    Kong, Desong
    Huang, Ruijian
    Chen, Yanfei
    Wang, Hao
    Gu, Ning
    Ma, Aixia
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [7] IMPACTS OF NATIONAL VOLUME-BASED PROCUREMENT POLICY ON PRICES OF NON-WINNING DRUGS IN CHINA: AN INTERRUPTED TIME SERIES
    Fu, M.
    Feng, L.
    Peng, J.
    Ma, Y.
    Zhao, M.
    Fang, Y.
    Lin, Y.
    Wu, Y.
    Jiang, M.
    VALUE IN HEALTH, 2024, 27 (12) : S319 - S319
  • [8] Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls
    Chen, Yilin
    Ji, Xu
    Xiao, Hong
    Unger, Joseph M.
    Cai, Yi
    Mao, Zongfu
    Yeung, Kai
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [9] Impacts of Chinese national centralized volume-based procurement policy targeting meropenem on prescription of designated antimicrobials for inpatients: an interrupted time series analysis
    Lin, Zhi-Hang
    Wang, Can-Ming
    Cai, Li-Li
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [10] The impact of “4 + 7” volume-based drug procurement on the volume, expenditures, and daily costs of antihypertensive drugs in Shenzhen, China: an interrupted time series analysis
    Ying Yang
    Ruiwen Tong
    Shicheng Yin
    Lining Mao
    Luxinyi Xu
    Siyu Hao
    Zongfu Mao
    BMC Health Services Research, 21
12345